These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 20186004)

  • 1. Allergy for a lifetime?
    Luger EO; Wegmann M; Achatz G; Worm M; Renz H; Radbruch A
    Allergol Int; 2010 Mar; 59(1):1-8. PubMed ID: 20186004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of long-lived allergen-specific plasma cells by mucosal allergen challenge.
    Luger EO; Fokuhl V; Wegmann M; Abram M; Tillack K; Achatz G; Manz RA; Worm M; Radbruch A; Renz H
    J Allergy Clin Immunol; 2009 Oct; 124(4):819-26.e4. PubMed ID: 19815119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term bortezomib treatment reduces allergen-specific IgE but fails to ameliorate chronic asthma in mice.
    Wegmann M; Lunding L; Orinska Z; Wong DM; Manz RA; Fehrenbach H
    Int Arch Allergy Immunol; 2012; 158(1):43-53. PubMed ID: 22212634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maintenance of long-lived plasma cells and serological memory despite mature and memory B cell depletion during CD20 immunotherapy in mice.
    DiLillo DJ; Hamaguchi Y; Ueda Y; Yang K; Uchida J; Haas KM; Kelsoe G; Tedder TF
    J Immunol; 2008 Jan; 180(1):361-71. PubMed ID: 18097037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting IgE production in mice and humans.
    Wu LC; Scheerens H
    Curr Opin Immunol; 2014 Dec; 31():8-15. PubMed ID: 25156315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenic long-lived plasma cells and their survival niches in autoimmunity, malignancy, and allergy.
    Winter O; Dame C; Jundt F; Hiepe F
    J Immunol; 2012 Dec; 189(11):5105-11. PubMed ID: 23169863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of action of anti-immunoglobulin E therapy.
    Soresi S; Togias A
    Allergy Asthma Proc; 2006; 27(2 Suppl 1):S15-23. PubMed ID: 16722327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma cells as an innovative target in autoimmune disease with renal manifestations.
    Hiepe F; Radbruch A
    Nat Rev Nephrol; 2016 Apr; 12(4):232-40. PubMed ID: 26923204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IgE-mediated allergen presentation and blocking antibodies: regulation of T-cell activation in allergy.
    van Neerven RJ; Knol EF; Ejrnaes A; Würtzen PA
    Int Arch Allergy Immunol; 2006; 141(2):119-29. PubMed ID: 16864979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-IgE antibodies for the treatment of IgE-mediated allergic diseases.
    Chang TW; Wu PC; Hsu CL; Hung AF
    Adv Immunol; 2007; 93():63-119. PubMed ID: 17383539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Omalizumab : other indications and unanswered questions.
    Mankad VS; Burks AW
    Clin Rev Allergy Immunol; 2005 Aug; 29(1):17-30. PubMed ID: 16222081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of omalizumab, a humanized monoclonal anti-IgE antibody, on nasal reactivity to allergen and local IgE synthesis.
    Corren J; Diaz-Sanchez D; Saxon A; Deniz Y; Reimann J; Sinclair D; Davancaze T; Adelman D
    Ann Allergy Asthma Immunol; 2004 Sep; 93(3):243-8. PubMed ID: 15478383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The anti-IgE antibody omalizumab as a probe to investigate the role of IgE in pathology.
    Mauro M; Incorvaia C; Formigoni C; Elia R; Russello M; Pellegrino D
    Panminerva Med; 2012 Dec; 54(4):305-12. PubMed ID: 23123583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a peptide conjugate vaccine for inducing therapeutic anti-IgE antibodies.
    Licari A; Castagnoli R; De Sando E; Marseglia GL
    Expert Opin Biol Ther; 2017 Apr; 17(4):429-434. PubMed ID: 28132528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Omalizumab in allergic diseases, a recent review.
    Vichyanond P
    Asian Pac J Allergy Immunol; 2011 Sep; 29(3):209-19. PubMed ID: 22053590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic allergen exposure drives accumulation of long-lived IgE plasma cells in the bone marrow, giving rise to serological memory.
    Asrat S; Kaur N; Liu X; Ben LH; Kajimura D; Murphy AJ; Sleeman MA; Limnander A; Orengo JM
    Sci Immunol; 2020 Jan; 5(43):. PubMed ID: 31924685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of anti-IgE therapy in combination with allergen specific immunotherapy for seasonal allergic rhinitis.
    Stock P; Rolinck-Werninghaus C; Wahn U; Hamelmann E
    BioDrugs; 2007; 21(6):403-10. PubMed ID: 18020623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic Potential of Monoclonal IgA Antibodies in Allergic Diseases: Suppressive Effect of IgA on Immune Responses Induced By Re-exposure to Antigen in Sensitized Mice by Monoclonal IgE Antibody That Binds to a Different Epitope of the Same Antigen.
    Yamaki K; Yoshino S
    Monoclon Antib Immunodiagn Immunother; 2015 Apr; 34(2):83-9. PubMed ID: 25897605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Internal images: human anti-idiotypic Fab antibodies mimic the IgE epitopes of grass pollen allergen Phl p 5a.
    Hantusch B; Knittelfelder R; Wallmann J; Krieger S; Szalai K; Untersmayr E; Vogel M; Stadler BM; Scheiner O; Boltz-Nitulescu G; Jensen-Jarolim E
    Mol Immunol; 2006 Jul; 43(14):2180-7. PubMed ID: 16510185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-classical B Cell Memory of Allergic IgE Responses.
    Saunders SP; Ma EGM; Aranda CJ; Curotto de Lafaille MA
    Front Immunol; 2019; 10():715. PubMed ID: 31105687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.